Demographics (3)
- AGE - Age at oral immunotherapy (OIT) enrollment (phv00508883.v1.p1)
- SEX - Biological sex (phv00508882.v1.p1)
- SEX - Biological sex (phv00508878.v1.p1)
Disease Events (3)
- ALLERGIC_RHINITIS - Allergic Rhinitis status (phv00508885.v1.p1)
- ASTHMA - Asthma status (phv00508884.v1.p1)
- ATOPIC_DERMITITIS - Atopic dermititis status (phv00508886.v1.p1)
Race and Ethnicity (1)
- RACE - Ethnicity (phv00508887.v1.p1)
Other (12)
- ANALYTE_TYPE - Analyte Type (phv00508892.v1.p1)
- ARM - Peanut treatment group in oral immunotherapy (OIT) (phv00508888.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00508891.v1.p1)
- COLLECTION_TIME - Peanut oral immunotherapy (OIT) time point when samples were collected (phv00508894.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00508877.v1.p1)
- IS_TUMOR - Tumor status (phv00508893.v1.p1)
- OUTCOME - OIT outcome at week-117 (phv00508889.v1.p1)
- SAMPLE_ID - Sample ID (phv00508890.v1.p1)
- SAMPLE_ID - Sample ID (phv00508880.v1.p1)
- SUBJECT_ID - Subject ID (phv00508881.v1.p1)
- SUBJECT_ID - Subject ID (phv00508876.v1.p1)
- SUBJECT_ID - Subject ID (phv00508879.v1.p1)